National Health (Weighted average disclosed price second transitional disclosure cycle) Amendment Determination 2012 (No. PB 7 of 2012) (Cth)
National Health (Weighted average disclosed price – second transitional disclosure cycle) Amendment Determination 2012
Instrument number PB 7 of 2012
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated 20 March 2012
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
Name of Determination
(1) This Determination is the National Health (Weighted average disclosed price – second transitional disclosure cycle) Amendment Determination 2012.
(2) This Determination may also be cited as PB 7 of 2012.
Commencement
This Determination commences on the day after it is registered.
3 Amendments to PB 82 of 2011
Schedule 1 amends the National Health (Weighted average disclosed price – second transitional disclosure cycle) Determination 2011 (PB 82 of 2011).
Schedule 1 Amendments
[1] Schedule 1, After
| 76 | Gemcitabine | Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | 30.41 | 32.70 |
insert:
| 76A | Gemcitabine | Solution concentrate for I.V. infusion 1g (as hydrochloride) in 25 mL | Injection | Gemcitabine Ebewe | 60.81 | 65.38 |
| 76B | Gemcitabine | Solution concentrate for I.V. infusion 2 g (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | 121.90 | 131.07 |
| 76C | Gemcitabine | Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 5 mL | Injection | Gemcitabine Ebewe | 12.31 | 13.24 |
| 76D | Gemcitabine | Solution for injection 1 g (as hydrochloride) in 26.3 mL | Injection | DBL Gemcitabine Injection | 60.81 | 65.38 |
| 76E | Gemcitabine | Solution for injection 2 g (as hydrochloride) in 52.6 mL | Injection | DBL Gemcitabine Injection | 121.90 | 131.07 |
| 76F | Gemcitabine | Solution for injection 200 mg (as hydrochloride) in 5.3 mL | Injection | DBL Gemcitabine Injection | 12.31 | 13.24 |
[2] Schedule 1, After
| 96 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Actavis 500 | 194.45 | 209.07 |
insert:
| 96A | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Tecan | 194.45 | 209.07 |
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0